Overview:
The
global cardiac pacemaker
market share is projected to reach USD 5.8 billion by 2030 at a 3.20%
CAGR during the forecast period 2022-2030. This certain growth can be
attributed to several factors from its functional features to its use in
countering diverse health-related issues. Cardiac pacemakers use in maintaining
regularity of the heart rhythm by sending electrical pulses to the heart has
gained traction in treating atrial fibrillation (AFib) which is also the chief
driver in taking the cardiac pacemaker market ahead. Furthermore, the rising
geriatric population, with a predicted number of 2.1billion by 2050, is
expanding the cardiac pacemaker market horizon.
However,
cardiac pacemakers incur high cost which can be a hurdle for the cardiac
pacemaker market during the forecast period. At the same time, its implantation
procedure requires surgery and risks of malfunctioning can add further woe.
Segmentation Analysis:
The global cardiac pacemaker market outlook can be segmented by type, technology, application, and end-users.
Based on type, the cardiac pacemaker market includes implantable, external cardiac pacemaker, and others.
Technology-wise, the cardiac pacemaker market comprises biventricular, single-chambered, dual-chambered, and others.
Application-based segmentation of the cardiac pacemaker market consists arrhythmias, congestive heart failure, and others. Arrhythmias segment can be sub-segmented into tachycardia, bradycardia, and others.
Based on the end-users, the market cardiac pacemaker includes hospitals, cardiac care centers, medical institutes, and others.
Market Insight:
The
cardiac pacemaker market has several global players who engage in strategic
developments to ace the field. These developments include merger, acquisition,
collaboration, new product launch, and other methods. For instance, Medtronic
is acquiring shares in Chinese company LifeTech Scientific to gain hold of the
Chinese market. Stryker, on the other hand, is trying to buy Boston Scientific
Corporation in a bid to expand their portfolio.
The
global cardiac pacemaker market players are Medtronic (U.S.), Abbott. (U.S.),
Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), LEPU MEDICAL (U.K),
SORIN Group (Europe), MEDICO S.p.A. (Europe), OSCOR Inc. (U.S.), and others.
Industry Trend:
Researchers
at the University of Ottawa Heart Institute completed the first successful
implant in 2018 of a Micra Leadless Transcatheter Pacing System, which is the
latest model of its category and the smallest leadless pacemaker in the world.
The process allows the machine to be implanted directly within the heart,
unlike other pacemakers.
Practitioners at Children's Hospital Los Angeles and the University of Southern California have developed a micropacemaker system requiring implantation in the pericardial sac which could be a breakthrough in cardiac surgery options for children and adults.
Regional Analysis:
Cardiac
pacemaker market insights includes regions namely the Americas, Europe, Asia
Pacific (APAC), and the Middle East & Africa (MEA).
The
Americas has the lead in the global market, and they can attribute this to a
superior infrastructure, and better healthcare policies. Furthermore, a
considerable patient pool is also playing in favor of cardiac pacemaker market.
Changing lifestyle and high healthcare expenditure are proving essential for
the regional market growth.
Europe
is following the lead and is experiencing considerable growth owing to regular
investment in research and development. Governments taking a keen interest in
the sector has a positive impact on the market.
The
APAC is the fastest growing region with India and China continually improving
their industrial landscape. In addition, many countries of this region are
emerging as a medical tourism hub and helping the regional cardiac pacemaker
market witness unprecedented growth. The MEA region’s growth will be slow due
to lack of infrastructure and poor economic regions.
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
United
States of America
No comments:
Post a Comment